{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,26]],"date-time":"2026-06-26T10:47:55Z","timestamp":1782470875695,"version":"3.54.5"},"reference-count":149,"publisher":"MDPI AG","issue":"7","license":[{"start":{"date-parts":[[2026,6,26]],"date-time":"2026-06-26T00:00:00Z","timestamp":1782432000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Vaccines"],"abstract":"<jats:p>DNA vaccines have emerged as a promising immunization platform, offering key advantages over conventional vaccine approaches, including superior stability, a favorable safety profile, rapid and flexible antigen design, and scalable manufacturing. However, their clinical efficacy has remained limited, primarily due to inefficient cellular uptake, poor endosomal escape, and degradation of the plasmid DNA within host cells. Recent advances have highlighted minicircle DNA (mcDNA) as a next-generation alternative to conventional plasmid vectors. mcDNA constructs are compact, backbone-free episomal vectors containing only the expression cassette, including the promoter, transgene, and polyadenylation signal, while lacking bacterial sequences such as antibiotic resistance genes and origins of replication. This reduced vector size reduced vector-driven innate immune activation and susceptibility to epigenetic silencing, thereby improving transfection efficiency and supporting more sustained transgene expression in both dividing and non-dividing cells. This review provides a comprehensive overview of mcDNA technology in the context of vaccine development, discussing its structural design and production principles, mechanistic advantages over conventional plasmid DNA, and current applications across infectious disease and cancer vaccine platforms. In addition, we explore recent delivery strategies to enhance mcDNA transfection and immunogenicity, summarize existing limitations that hinder translation into applications, and outline future directions to optimize mcDNA-based vaccine technologies.<\/jats:p>","DOI":"10.3390\/vaccines14070563","type":"journal-article","created":{"date-parts":[[2026,6,26]],"date-time":"2026-06-26T08:43:57Z","timestamp":1782463437000},"page":"563","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Minicircle DNA Vaccines: Overcoming Delivery and Expression Barriers in Next-Generation Immunization"],"prefix":"10.3390","volume":"14","author":[{"given":"Ibtihal S.","family":"Alduhaymi","sequence":"first","affiliation":[{"name":"Advanced Diagnostics and Therapeutics Institute, Health Sector, King Abdulaziz City for Science and Technology (KACST), Riyadh 11442, Saudi Arabia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Majed A.","family":"Majrashi","sequence":"additional","affiliation":[{"name":"Bioengineering Institute, Health Sector, King Abdulaziz City for Science and Technology (KACST), Riyadh 11442, Saudi Arabia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3433-9427","authenticated-orcid":false,"given":"Ibrahim A.","family":"Alradwan","sequence":"additional","affiliation":[{"name":"Advanced Diagnostics and Therapeutics Institute, Health Sector, King Abdulaziz City for Science and Technology (KACST), Riyadh 11442, Saudi Arabia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Faisal S.","family":"Alagrafi","sequence":"additional","affiliation":[{"name":"Aging Research Institute, Health Sector, King Abdulaziz City for Science and Technology (KACST), Riyadh 11442, Saudi Arabia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Musaad A.","family":"Altammami","sequence":"additional","affiliation":[{"name":"Wellness and Preventative Medicine Institute, Health Sector, King Abdulaziz City for Science and Technology (KACST), Riyadh 11442, Saudi Arabia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ahmad M.","family":"Aldossary","sequence":"additional","affiliation":[{"name":"Wellness and Preventative Medicine Institute, Health Sector, King Abdulaziz City for Science and Technology (KACST), Riyadh 11442, Saudi Arabia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9614-7557","authenticated-orcid":false,"given":"Fahad A.","family":"Almughem","sequence":"additional","affiliation":[{"name":"Advanced Diagnostics and Therapeutics Institute, Health Sector, King Abdulaziz City for Science and Technology (KACST), Riyadh 11442, Saudi Arabia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0358-4155","authenticated-orcid":false,"given":"Abdullah A.","family":"Alshehri","sequence":"additional","affiliation":[{"name":"Advanced Diagnostics and Therapeutics Institute, Health Sector, King Abdulaziz City for Science and Technology (KACST), Riyadh 11442, Saudi Arabia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mohannad M.","family":"Fallatah","sequence":"additional","affiliation":[{"name":"Advanced Diagnostics and Therapeutics Institute, Health Sector, King Abdulaziz City for Science and Technology (KACST), Riyadh 11442, Saudi Arabia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nojoud","family":"Al Fayez","sequence":"additional","affiliation":[{"name":"Advanced Diagnostics and Therapeutics Institute, Health Sector, King Abdulaziz City for Science and Technology (KACST), Riyadh 11442, Saudi Arabia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Essam A.","family":"Tawfik","sequence":"additional","affiliation":[{"name":"Advanced Diagnostics and Therapeutics Institute, Health Sector, King Abdulaziz City for Science and Technology (KACST), Riyadh 11442, Saudi Arabia"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1968","published-online":{"date-parts":[[2026,6,26]]},"reference":[{"key":"ref_1","unstructured":"Leifert, J.A., and Whitton, J.L. (2013). Immune responses to DNA vaccines: Induction of CD8 T cells. Madame Curie Bioscience Database [Internet], Landes Bioscience."},{"key":"ref_2","doi-asserted-by":"crossref","unstructured":"Hobernik, D., and Bros, M. (2018). DNA vaccines\u2014How far from clinical use?. Int. J. Mol. Sci., 19.","DOI":"10.3390\/ijms19113605"},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"2850","DOI":"10.4049\/jimmunol.165.5.2850","article-title":"Distribution of DNA vaccines determines their immunogenicity after intramuscular injection in mice","volume":"165","author":"Dupuis","year":"2000","journal-title":"J. Immunol."},{"key":"ref_4","doi-asserted-by":"crossref","unstructured":"Kozak, M., and Hu, J. (2024). DNA vaccines: Their formulations, engineering and delivery. Vaccines, 12.","DOI":"10.3390\/vaccines12010071"},{"key":"ref_5","first-page":"395","article-title":"Transcriptional silencing is associated with extensive methylation of the CMV promoter following adenoviral gene delivery to muscle","volume":"6","author":"Brooks","year":"2004","journal-title":"J. Gene Med. A Cross-Discip. J. Res. Sci. Gene Transf. Its Clin. Appl."},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"950","DOI":"10.1016\/j.cels.2022.11.005","article-title":"The sound of silence: Transgene silencing in mammalian cell engineering","volume":"13","author":"Cabrera","year":"2022","journal-title":"Cell Syst."},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1038\/s41579-023-00926-x","article-title":"Plasmids, a molecular cornerstone of antimicrobial resistance in the One Health era","volume":"22","author":"Top","year":"2024","journal-title":"Nat. Rev. Microbiol."},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"731","DOI":"10.1006\/mthe.2002.0598","article-title":"CpG-depleted plasmid DNA vectors with enhanced safety and long-term gene expression in vivo","volume":"5","author":"Yew","year":"2002","journal-title":"Mol. Ther."},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"e714","DOI":"10.1002\/mco2.714","article-title":"The interaction of innate immune and adaptive immune system","volume":"5","author":"Wang","year":"2024","journal-title":"MedComm"},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"709","DOI":"10.1146\/annurev.immunol.20.100301.064842","article-title":"CpG motifs in bacterial DNA and their immune effects","volume":"20","author":"Krieg","year":"2002","journal-title":"Annu. Rev. Immunol."},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"495","DOI":"10.1016\/S1525-0016(03)00168-0","article-title":"Minicircle DNA vectors devoid of bacterial DNA result in persistent and high-level transgene expression in vivo","volume":"8","author":"Chen","year":"2003","journal-title":"Mol. Ther."},{"key":"ref_12","doi-asserted-by":"crossref","first-page":"102682","DOI":"10.1016\/j.omtn.2025.102682","article-title":"Progress and prospect of minicircle as a minimized non-viral DNA vector in gene therapy and regenerative medicine","volume":"36","author":"Chanani","year":"2025","journal-title":"Mol. Ther. Nucleic Acids"},{"key":"ref_13","doi-asserted-by":"crossref","unstructured":"Hardee, C.L., Ar\u00e9valo-Soliz, L.M., Hornstein, B.D., and Zechiedrich, L. (2017). Advances in non-viral DNA vectors for gene therapy. Genes, 8.","DOI":"10.3390\/genes8020065"},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"1526","DOI":"10.1038\/mt.2013.85","article-title":"Minicircle DNA is superior to plasmid DNA in eliciting antigen-specific CD8+ T-cell responses","volume":"21","author":"Dietz","year":"2013","journal-title":"Mol. Ther."},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1038\/mt.2012.244","article-title":"Minicircle DNA vectors achieve sustained expression reflected by active chromatin and transcriptional level","volume":"21","author":"Maniar","year":"2013","journal-title":"Mol. Ther."},{"key":"ref_16","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1111\/j.0105-2896.2004.00142.x","article-title":"Cross-presentation, dendritic cell subsets, and the generation of immunity to cellular antigens","volume":"199","author":"Heath","year":"2004","journal-title":"Immunol. Rev."},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"627","DOI":"10.1007\/s00262-017-2111-y","article-title":"Linear doggybone DNA vaccine induces similar immunological responses to conventional plasmid DNA independently of immune recognition by TLR9 in a pre-clinical model","volume":"67","author":"Allen","year":"2018","journal-title":"Cancer Immunol. Immunother."},{"key":"ref_18","doi-asserted-by":"crossref","first-page":"645","DOI":"10.1038\/gt.2014.37","article-title":"Comparative analysis of enzymatically produced novel linear DNA constructs with plasmids for use as DNA vaccines","volume":"21","author":"Walters","year":"2014","journal-title":"Gene Ther."},{"key":"ref_19","doi-asserted-by":"crossref","first-page":"e013812","DOI":"10.1136\/jitc-2025-013812","article-title":"Synthetic DNA vaccine platform elicits potent immunity where electroporated naked-mRNA is non-immunogenic","volume":"14","author":"Tonini","year":"2026","journal-title":"J. Immunother. Cancer"},{"key":"ref_20","doi-asserted-by":"crossref","first-page":"1287","DOI":"10.1038\/nbt.1708","article-title":"A robust system for production of minicircle DNA vectors","volume":"28","author":"Kay","year":"2010","journal-title":"Nat. Biotechnol."},{"key":"ref_21","doi-asserted-by":"crossref","first-page":"285","DOI":"10.18609\/cgti.2017.020","article-title":"Minicircles: Next-generation gene vectors","volume":"3","author":"Shankar","year":"2017","journal-title":"Cell Gene Ther. Insights"},{"key":"ref_22","doi-asserted-by":"crossref","unstructured":"Ventura, C., Eus\u00e9bio, D., Gon\u00e7alves, A.M., Barroca-Ferreira, J., Costa, D., Cui, Z., Passarinha, L.A., and Sousa, \u00c2. (2022). Maximization of the Minicircle DNA Vaccine Production Expressing SARS-CoV-2 RBD. Biomedicines, 10.","DOI":"10.3390\/biomedicines10050990"},{"key":"ref_23","doi-asserted-by":"crossref","first-page":"103982","DOI":"10.1016\/j.xpro.2025.103982","article-title":"Protocol for minicircle production for gene therapy without subsequent cleanup steps","volume":"6","author":"Do","year":"2025","journal-title":"STAR Protoc."},{"key":"ref_24","doi-asserted-by":"crossref","first-page":"1778","DOI":"10.1038\/s42003-025-09157-7","article-title":"Plasmid2MC: Efficient cell-free generation of high-purity minicircle DNA for genome editing in mammalian cells","volume":"8","author":"Oliynyk","year":"2025","journal-title":"Commun. Biol."},{"key":"ref_25","doi-asserted-by":"crossref","first-page":"1335","DOI":"10.1021\/bp060046h","article-title":"Development of a highly productive and scalable plasmid DNA production platform","volume":"22","author":"Listner","year":"2006","journal-title":"Biotechnol. Prog."},{"key":"ref_26","doi-asserted-by":"crossref","first-page":"865","DOI":"10.1016\/S0141-0229(03)00205-9","article-title":"Industrial scale production of plasmid DNA for vaccine and gene therapy: Plasmid design, production, and purification","volume":"33","author":"Prather","year":"2003","journal-title":"Enzym. Microb. Technol."},{"key":"ref_27","doi-asserted-by":"crossref","first-page":"317","DOI":"10.1089\/hum.1995.6.3-317","article-title":"Bacterial lipopolysaccharide copurifies with plasmid DNA: Implications for animal models and human gene therapy","volume":"6","author":"Wicks","year":"1995","journal-title":"Hum. Gene Ther."},{"key":"ref_28","doi-asserted-by":"crossref","first-page":"505","DOI":"10.1002\/bit.22415","article-title":"Plasmid DNA production combining antibiotic-free selection, inducible high yield fermentation, and novel autolytic purification","volume":"104","author":"Carnes","year":"2009","journal-title":"Biotechnol. Bioeng."},{"key":"ref_29","doi-asserted-by":"crossref","unstructured":"Brookwell, A., Oza, J.P., and Caschera, F. (2021). Biotechnology Applications of Cell-Free Expression Systems. Life, 11.","DOI":"10.3390\/life11121367"},{"key":"ref_30","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1136\/jmedgenet-2018-105405","article-title":"Bacteria-free minicircle DNA system to generate integration-free CAR-T cells","volume":"56","author":"Cheng","year":"2019","journal-title":"J. Med. Genet."},{"key":"ref_31","doi-asserted-by":"crossref","first-page":"gkaf889","DOI":"10.1093\/nar\/gkaf889","article-title":"Synthesizing supercoiled circular DNA molecules in vitro","volume":"53","author":"Rezaei","year":"2025","journal-title":"Nucleic Acids Res."},{"key":"ref_32","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1089\/hgtb.2018.046","article-title":"Production and Purification of Supercoiled Minicircles by a Combination of In Vitro Endonuclease Nicking and Hydrophobic Interaction Chromatography","volume":"29","author":"Alves","year":"2018","journal-title":"Hum. Gene Ther. Methods"},{"key":"ref_33","doi-asserted-by":"crossref","first-page":"136","DOI":"10.1016\/j.chroma.2016.03.035","article-title":"Development of a nicking endonuclease-assisted method for the purification of minicircles","volume":"1443","author":"Alves","year":"2016","journal-title":"J. Chromatogr. A"},{"key":"ref_34","doi-asserted-by":"crossref","first-page":"1739","DOI":"10.1002\/bit.28667","article-title":"Selective hydrophobic interaction chromatography for high purity of supercoiled DNA plasmids","volume":"121","author":"Sedlar","year":"2024","journal-title":"Biotechnol. Bioeng."},{"key":"ref_35","doi-asserted-by":"crossref","first-page":"3544","DOI":"10.1002\/jssc.201600375","article-title":"Minicircle DNA purification using a CIM\u00ae DEAE-1 monolithic support","volume":"39","author":"Diamantino","year":"2016","journal-title":"J. Sep. Sci."},{"key":"ref_36","doi-asserted-by":"crossref","unstructured":"Alves, C.P.A., Prazeres, D.M.F., and Monteiro, G.A. (2021). Minicircle Biopharmaceuticals\u2013An Overview of Purification Strategies. Front. Chem. Eng., 2.","DOI":"10.3389\/fceng.2020.612594"},{"key":"ref_37","doi-asserted-by":"crossref","first-page":"23125","DOI":"10.1038\/srep23125","article-title":"Minicircle DNA Provides Enhanced and Prolonged Transgene Expression Following Airway Gene Transfer","volume":"6","author":"Munye","year":"2016","journal-title":"Sci. Rep."},{"key":"ref_38","doi-asserted-by":"crossref","first-page":"1341","DOI":"10.1038\/sj.gt.3300540","article-title":"A new DNA vehicle for nonviral gene delivery: Supercoiled minicircle","volume":"4","author":"Darquet","year":"1997","journal-title":"Gene Ther."},{"key":"ref_39","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1517\/17425247.1.1.115","article-title":"Reducing the immunostimulatory activity of CpG-containing plasmid DNA vectors for non-viral gene therapy","volume":"1","author":"Yew","year":"2004","journal-title":"Expert Opin. Drug Deliv."},{"key":"ref_40","doi-asserted-by":"crossref","first-page":"3792","DOI":"10.1093\/nar\/27.19.3792","article-title":"Plasmid DNA size does not affect the physicochemical properties of lipoplexes but modulates gene transfer efficiency","volume":"27","author":"Kreiss","year":"1999","journal-title":"Nucleic Acids Res."},{"key":"ref_41","doi-asserted-by":"crossref","first-page":"671","DOI":"10.2174\/156652306779010688","article-title":"Intracellular trafficking of plasmids for gene therapy: Mechanisms of cytoplasmic movement and nuclear import","volume":"6","author":"Vaughan","year":"2006","journal-title":"Curr. Gene Ther."},{"key":"ref_42","doi-asserted-by":"crossref","first-page":"1306","DOI":"10.4161\/hv.28077","article-title":"Safety and efficacy of DNA vaccines: Plasmids vs. minicircles","volume":"10","author":"Stenler","year":"2014","journal-title":"Hum. Vaccines Immunother."},{"key":"ref_43","doi-asserted-by":"crossref","unstructured":"Ata-Abadi, N.S., Rezaei, N., Dormiani, K., and Nasr-Esfahani, M.H. (2017). Production of minicircle DNA vectors using site-specific recombinases. Site-Specific Recombinases: Methods and Protocols, Springer.","DOI":"10.1007\/978-1-4939-7169-5_20"},{"key":"ref_44","first-page":"17","article-title":"Single-Use Fermentors for Plasmid and Minicircle DNA Production","volume":"22","author":"Weber","year":"2024","journal-title":"BioProcess Int."},{"key":"ref_45","doi-asserted-by":"crossref","first-page":"102911","DOI":"10.1016\/j.omtn.2026.102911","article-title":"Reprogramming innate immunity through viral interference: A double-edged strategy for enhancing and containing gene therapies","volume":"37","author":"Liu","year":"2026","journal-title":"Mol. Ther. Nucleic Acids"},{"key":"ref_46","doi-asserted-by":"crossref","unstructured":"Bertolini, T.B., Shirley, J.L., Zolotukhin, I., Li, X., Kaisho, T., Xiao, W., Kumar, S.R.P., and Herzog, R.W. (2021). Effect of CpG Depletion of Vector Genome on CD8(+) T Cell Responses in AAV Gene Therapy. Front. Immunol., 12.","DOI":"10.3389\/fimmu.2021.672449"},{"key":"ref_47","doi-asserted-by":"crossref","unstructured":"Li, N., Kumar, S.R.P., Cao, D., Munoz-Melero, M., Arisa, S., Brian, B.A., Greenwood, C.M., Yamada, K., Duan, D., and Herzog, R.W. (2024). Redundancy in Innate Immune Pathways That Promote CD8+ T-Cell Responses in AAV1 Muscle Gene Transfer. Viruses, 16.","DOI":"10.3390\/v16101507"},{"key":"ref_48","doi-asserted-by":"crossref","first-page":"1187","DOI":"10.1016\/j.ymthe.2017.03.003","article-title":"Sequence-Modified Antibiotic Resistance Genes Provide Sustained Plasmid-Mediated Transgene Expression in Mammals","volume":"25","author":"Lu","year":"2017","journal-title":"Mol. Ther."},{"key":"ref_49","doi-asserted-by":"crossref","first-page":"539","DOI":"10.1016\/j.tibtech.2013.06.001","article-title":"Marker-free plasmids for biotechnological applications\u2014Implications and perspectives","volume":"31","author":"Oliveira","year":"2013","journal-title":"Trends Biotechnol."},{"key":"ref_50","doi-asserted-by":"crossref","unstructured":"McCullough, K.C., and Sharma, R. (2017). Dendritic Cell Endocytosis Essential for Viruses and Vaccines. Biology of Myelomonocytic Cells, InTech.","DOI":"10.5772\/67779"},{"key":"ref_51","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1016\/j.actbio.2018.08.033","article-title":"Engineering DNA vaccines against infectious diseases","volume":"80","author":"Lee","year":"2018","journal-title":"Acta Biomater."},{"key":"ref_52","unstructured":"Steinman, R.M., Bona, C., and Inaba, K. (2013). Dendritic cells: Important adjuvants during DNA vaccination. Madame Curie Bioscience Database [Internet], Landes Bioscience."},{"key":"ref_53","doi-asserted-by":"crossref","first-page":"1575","DOI":"10.3390\/life15101575","article-title":"Cross-Priming and Cross-Tolerance After Intramuscular mRNA Vaccination for Viral Infections: Feasibility and Implications","volume":"15","author":"Mueller","year":"2025","journal-title":"Life"},{"key":"ref_54","doi-asserted-by":"crossref","unstructured":"Joubert, V., Andr\u00e9, F.M., Schmeer, M., Schleef, M., and Mir, L.M. (2013). Increased efficiency of minicircles versus plasmids under gene electrotransfer suboptimal conditions: An influence of the extracellular matrix. Minicircle and Miniplasmid DNA Vectors: The Future of Nonviral and Viral Gene Transfer, Wiley.","DOI":"10.1002\/9783527670420.ch13"},{"key":"ref_55","doi-asserted-by":"crossref","unstructured":"Schleef, M. (2013). Minicircle and Miniplasmid DNA Vectors: The Future of Non-Viral and Viral Gene Transfer, John Wiley & Sons.","DOI":"10.1002\/9783527670420"},{"key":"ref_56","doi-asserted-by":"crossref","first-page":"168297","DOI":"10.1016\/j.jmb.2023.168297","article-title":"DNA Vaccines: History, Molecular Mechanisms and Future Perspectives","volume":"435","author":"Pagliari","year":"2023","journal-title":"J. Mol. Biol."},{"key":"ref_57","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1016\/S0005-2736(00)00226-1","article-title":"Membrane perturbation and the mechanism of lipid-mediated transfer of DNA into cells","volume":"1467","author":"Mui","year":"2000","journal-title":"Biochim. Biophys. Acta"},{"key":"ref_58","doi-asserted-by":"crossref","unstructured":"Trombone, A.P., Silva, C.L., Lima, K.M., Oliver, C., Jamur, M.C., Prescott, A.R., and Coelho-Castelo, A.A. (2007). Endocytosis of DNA-Hsp65 alters the pH of the late endosome\/lysosome and interferes with antigen presentation. PLoS ONE, 2.","DOI":"10.1371\/journal.pone.0000923"},{"key":"ref_59","doi-asserted-by":"crossref","unstructured":"Tregoning, J.S., and Kinnear, E. (2014). Using Plasmids as DNA Vaccines for Infectious Diseases. Microbiol. Spectr., 2.","DOI":"10.1128\/microbiolspec.PLAS-0028-2014"},{"key":"ref_60","doi-asserted-by":"crossref","first-page":"1379","DOI":"10.1021\/bm400015b","article-title":"Nonviral gene delivery to neural stem cells with minicircles by microporation","volume":"14","author":"Madeira","year":"2013","journal-title":"Biomacromolecules"},{"key":"ref_61","doi-asserted-by":"crossref","first-page":"1737","DOI":"10.1007\/s11033-019-04624-x","article-title":"Episomal minicircles persist in periods of transcriptional inactivity and can be transmitted through somatic cell nuclear transfer into bovine embryos","volume":"46","author":"Wagner","year":"2019","journal-title":"Mol. Biol. Rep."},{"key":"ref_62","doi-asserted-by":"crossref","first-page":"339","DOI":"10.1016\/j.omtn.2017.04.013","article-title":"Low-Dose Gene Therapy for Murine PKU Using Episomal Naked DNA Vectors Expressing PAH from Its Endogenous Liver Promoter","volume":"7","author":"Schlegel","year":"2017","journal-title":"Mol. Ther. Nucleic Acids"},{"key":"ref_63","doi-asserted-by":"crossref","unstructured":"Serra, A.S., Eus\u00e9bio, D., Neves, A.R., Albuquerque, T., Bhatt, H., Biswas, S., Costa, D., and Sousa, \u00c2. (2021). Synthesis and Characterization of Mannosylated Formulations to Deliver a Minicircle DNA Vaccine. Pharmaceutics, 13.","DOI":"10.3390\/pharmaceutics13050673"},{"key":"ref_64","doi-asserted-by":"crossref","first-page":"1924","DOI":"10.1128\/JVI.02757-13","article-title":"In vivo electroporation of minicircle DNA as a novel method of vaccine delivery to enhance HIV-1-specific immune responses","volume":"88","author":"Wang","year":"2014","journal-title":"J. Virol."},{"key":"ref_65","doi-asserted-by":"crossref","unstructured":"Chen, H., Gu, Y., Song, L., and Si, L. (2025). Next-generation vaccines against bacterial pathogens: mRNA and beyond. Front. Immunol., 16.","DOI":"10.3389\/fimmu.2025.1709794"},{"key":"ref_66","doi-asserted-by":"crossref","first-page":"2203","DOI":"10.4161\/hv.25086","article-title":"Use of Staby((R)) technology for development and production of DNA vaccines free of antibiotic resistance gene","volume":"9","author":"Reschner","year":"2013","journal-title":"Hum. Vaccines Immunother."},{"key":"ref_67","doi-asserted-by":"crossref","first-page":"26698","DOI":"10.1038\/s41598-024-78049-3","article-title":"Minicircle-based vaccine induces potent T-cell and antibody responses against hepatitis C virus","volume":"14","author":"Czarnota","year":"2024","journal-title":"Sci. Rep."},{"key":"ref_68","doi-asserted-by":"crossref","first-page":"e0254923","DOI":"10.1128\/spectrum.02549-23","article-title":"Enhanced immunogenicity elicited by a novel DNA vaccine encoding the SARS-CoV-2 S1 protein fused to the optimized flagellin of Salmonella typhimurium in mice","volume":"11","author":"Song","year":"2023","journal-title":"Microbiol. Spectr."},{"key":"ref_69","doi-asserted-by":"crossref","first-page":"112","DOI":"10.1038\/s41577-025-01215-9","article-title":"Targets of protective immunity and opportunities in hepatitis C virus vaccine development","volume":"26","author":"Park","year":"2026","journal-title":"Nat. Rev. Immunol."},{"key":"ref_70","doi-asserted-by":"crossref","first-page":"5036","DOI":"10.1016\/j.vaccine.2020.05.042","article-title":"Viral vectored hepatitis C virus vaccines generate pan-genotypic T cell responses to conserved subdominant epitopes","volume":"38","author":"Donnison","year":"2020","journal-title":"Vaccine"},{"key":"ref_71","doi-asserted-by":"crossref","first-page":"a036970","DOI":"10.1101\/cshperspect.a036970","article-title":"Animal Models of Hepatitis C Virus Infection","volume":"10","author":"Ploss","year":"2020","journal-title":"Cold Spring Harb. Perspect. Med."},{"key":"ref_72","doi-asserted-by":"crossref","first-page":"e180819","DOI":"10.1172\/jci.insight.180819","article-title":"Focusing HIV-1 Gag T cell responses to highly conserved regions by DNA vaccination in HVTN 119","volume":"9","author":"Kalams","year":"2024","journal-title":"JCI Insight"},{"key":"ref_73","doi-asserted-by":"crossref","first-page":"1881","DOI":"10.1016\/S0140-6736(08)61591-3","article-title":"Efficacy assessment of a cell-mediated immunity HIV-1 vaccine (the Step Study): A double-blind, randomised, placebo-controlled, test-of-concept trial","volume":"372","author":"Buchbinder","year":"2008","journal-title":"Lancet"},{"key":"ref_74","doi-asserted-by":"crossref","first-page":"1089","DOI":"10.1056\/NEJMoa2031499","article-title":"Vaccine Efficacy of ALVAC-HIV and Bivalent Subtype C gp120\u2013MF59 in Adults","volume":"384","author":"Bekker","year":"2021","journal-title":"N. Engl. J. Med."},{"key":"ref_75","doi-asserted-by":"crossref","first-page":"9154","DOI":"10.1128\/JVI.00652-15","article-title":"An Enhanced Synthetic Multiclade DNA Prime Induces Improved Cross-Clade-Reactive Functional Antibodies when Combined with an Adjuvanted Protein Boost in Nonhuman Primates","volume":"89","author":"Pollara","year":"2015","journal-title":"J. Virol."},{"key":"ref_76","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1128\/JVI.01529-18","article-title":"Priming with a Potent HIV-1 DNA Vaccine Frames the Quality of Immune Responses prior to a Poxvirus and Protein Boost","volume":"93","author":"Asbach","year":"2019","journal-title":"J. Virol."},{"key":"ref_77","doi-asserted-by":"crossref","first-page":"123959","DOI":"10.1016\/j.ijpharm.2024.123959","article-title":"Mannosylated polyethylenimine-cholesterol-based nanoparticles for targeted delivery of minicircle DNA vaccine against COVID-19 to antigen-presenting cells","volume":"654","author":"Paul","year":"2024","journal-title":"Int. J. Pharm."},{"key":"ref_78","doi-asserted-by":"crossref","first-page":"200","DOI":"10.1007\/s12032-023-02060-3","article-title":"The future of cancer immunotherapy: DNA vaccines leading the way","volume":"40","author":"Pandya","year":"2023","journal-title":"Med. Oncol."},{"key":"ref_79","doi-asserted-by":"crossref","first-page":"15","DOI":"10.33696\/immunology.6.188","article-title":"Personalized neoantigen DNA cancer vaccines: Current status and future perspectives","volume":"6","author":"Viborg","year":"2024","journal-title":"J. Cell. Immunol."},{"key":"ref_80","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1038\/s41541-023-00671-5","article-title":"DNA based neoepitope vaccination induces tumor control in syngeneic mouse models","volume":"8","author":"Viborg","year":"2023","journal-title":"npj Vaccines"},{"key":"ref_81","doi-asserted-by":"crossref","first-page":"692","DOI":"10.1038\/nature14426","article-title":"Mutant MHC class II epitopes drive therapeutic immune responses to cancer","volume":"520","author":"Kreiter","year":"2015","journal-title":"Nature"},{"key":"ref_82","doi-asserted-by":"crossref","first-page":"e1223002","DOI":"10.1080\/2162402X.2016.1223002","article-title":"Mini-intronic plasmid vaccination elicits tolerant LAG3(+) CD8(+) T cells and inferior antitumor responses","volume":"5","author":"Colluru","year":"2016","journal-title":"Oncoimmunology"},{"key":"ref_83","doi-asserted-by":"crossref","unstructured":"Giusti, A., Eus\u00e9bio, D., Costa, M., Silveira, I., Biswas, S., Costa, D., and Sousa, \u00c2. (2026). Development of RALA-Based Mannosylated Nanocarriers for Targeted Delivery of Minicircle DNA Vaccines Encoding HPV-16 Oncogenes. Vaccines, 14.","DOI":"10.3390\/vaccines14010018"},{"key":"ref_84","doi-asserted-by":"crossref","first-page":"146","DOI":"10.1186\/s13046-019-1154-7","article-title":"Cancer DNA vaccines: Current preclinical and clinical developments and future perspectives","volume":"38","author":"Lopes","year":"2019","journal-title":"J. Exp. Clin. Cancer Res."},{"key":"ref_85","doi-asserted-by":"crossref","unstructured":"Almeida, A.M., Eusebio, D., Queiroz, J.A., Sousa, F., and Sousa, \u00c2. (2020). Minicircle DNA vaccine purification and E7 antigen expression assessment. DNA Vaccines: Methods and Protocols, Springer.","DOI":"10.1007\/978-1-0716-0872-2_11"},{"key":"ref_86","doi-asserted-by":"crossref","first-page":"1044","DOI":"10.1038\/s41591-024-02894-y","article-title":"Personalized neoantigen vaccine and pembrolizumab in advanced hepatocellular carcinoma: A phase 1\/2 trial","volume":"30","author":"Yarchoan","year":"2024","journal-title":"Nat. Med."},{"key":"ref_87","doi-asserted-by":"crossref","unstructured":"Lu, B., Lim, J.M., Yu, B., Song, S., Neeli, P., Sobhani, N., K, P., Bonam, S.R., Kurapati, R., and Zheng, J. (2024). The next-generation DNA vaccine platforms and delivery systems: Advances, challenges and prospects. Front. Immunol., 15.","DOI":"10.3389\/fimmu.2024.1332939"},{"key":"ref_88","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1007\/978-1-4939-2727-2_18","article-title":"Minicircle: Next Generation DNA Vectors for Vaccination","volume":"1317","author":"Schleef","year":"2015","journal-title":"Methods Mol. Biol."},{"key":"ref_89","doi-asserted-by":"crossref","first-page":"170","DOI":"10.1016\/j.jconrel.2024.12.002","article-title":"Enhancing non-viral DNA delivery systems: Recent advances in improving efficiency and target specificity","volume":"378","author":"Bremmell","year":"2025","journal-title":"J. Control. Release"},{"key":"ref_90","doi-asserted-by":"crossref","unstructured":"Neeli, P., Chai, D., Roy, D., Prajapati, S., and Bonam, S.R. (2025). DNA Vaccines in the Post-mRNA Era: Engineering, Applications, and Emerging Innovations. Int. J. Mol. Sci., 26.","DOI":"10.3390\/ijms26178716"},{"key":"ref_91","doi-asserted-by":"crossref","unstructured":"Staurenghi, F., McClements, M.E., Salman, A., and MacLaren, R.E. (2022). Minicircle Delivery to the Neural Retina as a Gene Therapy Approach. Int. J. Mol. Sci., 23.","DOI":"10.3390\/ijms231911673"},{"key":"ref_92","doi-asserted-by":"crossref","first-page":"184","DOI":"10.1186\/s13287-021-02245-5","article-title":"Gene engineered mesenchymal stem cells: Greater transgene expression and efficacy with minicircle vs. plasmid DNA vectors in a mouse model of acute lung injury","volume":"12","author":"Florian","year":"2021","journal-title":"Stem Cell Res. Ther."},{"key":"ref_93","doi-asserted-by":"crossref","first-page":"2380","DOI":"10.1016\/j.bbamem.2016.04.001","article-title":"Gold nanoparticles in model biological membranes: A computational perspective","volume":"1858","author":"Rossi","year":"2016","journal-title":"Biochim. Biophys. Acta (BBA)-Biomembr."},{"key":"ref_94","doi-asserted-by":"crossref","unstructured":"Hettinga, J., and Carlisle, R. (2020). Vaccination into the Dermal Compartment: Techniques, Challenges, and Prospects. Vaccines, 8.","DOI":"10.3390\/vaccines8030534"},{"key":"ref_95","doi-asserted-by":"crossref","first-page":"e00407","DOI":"10.1128\/AEM.00407-19","article-title":"A novel Cre recombinase-mediated in vivo minicircle DNA (CRIM) vaccine provides partial protection against Newcastle disease virus","volume":"85","author":"Jiang","year":"2019","journal-title":"Appl. Environ. Microbiol."},{"key":"ref_96","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1016\/j.jbiosc.2025.05.005","article-title":"Preparation of minicircle DNA vectors for gene knock-in to mammalian cells","volume":"140","author":"Kawabe","year":"2025","journal-title":"J. Biosci. Bioeng."},{"key":"ref_97","doi-asserted-by":"crossref","first-page":"2055","DOI":"10.1016\/j.ijbiomac.2021.05.192","article-title":"A review of the tortuous path of nonviral gene delivery and recent progress","volume":"183","author":"Sharma","year":"2021","journal-title":"Int. J. Biol. Macromol."},{"key":"ref_98","doi-asserted-by":"crossref","first-page":"541","DOI":"10.1038\/nrg3763","article-title":"Non-viral vectors for gene-based therapy","volume":"15","author":"Yin","year":"2014","journal-title":"Nat. Rev. Genet."},{"key":"ref_99","doi-asserted-by":"crossref","first-page":"353","DOI":"10.1517\/14712598.2015.996544","article-title":"Minicircle DNA vectors for gene therapy: Advances and applications","volume":"15","author":"Gaspar","year":"2015","journal-title":"Expert Opin. Biol. Ther."},{"key":"ref_100","doi-asserted-by":"crossref","first-page":"146","DOI":"10.1089\/nat.2018.0721","article-title":"Lipid Nanoparticles Enabling Gene Therapies: From Concepts to Clinical Utility","volume":"28","author":"Kulkarni","year":"2018","journal-title":"Nucleic Acid Ther."},{"key":"ref_101","doi-asserted-by":"crossref","unstructured":"Palmerston Mendes, L., Pan, J., and Torchilin, V.P. (2017). Dendrimers as Nanocarriers for Nucleic Acid and Drug Delivery in Cancer Therapy. Molecules, 22.","DOI":"10.3390\/molecules22091401"},{"key":"ref_102","doi-asserted-by":"crossref","first-page":"102584","DOI":"10.1016\/j.mtbio.2025.102584","article-title":"mRNA delivery systems 2.0: Engineering extrahepatic delivery for non-vaccine therapeutics","volume":"35","author":"Dalabehera","year":"2025","journal-title":"Mater. Today Bio"},{"key":"ref_103","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1016\/j.jconrel.2016.06.024","article-title":"Part I: Minicircle vector technology limits DNA size restrictions on ex vivo gene delivery using nanoparticle vectors: Overcoming a translational barrier in neural stem cell therapy","volume":"238","author":"Fernandes","year":"2016","journal-title":"J. Control. Release"},{"key":"ref_104","doi-asserted-by":"crossref","first-page":"8560","DOI":"10.1039\/C7NR00811B","article-title":"A fusion of minicircle DNA and nanoparticle delivery technologies facilitates therapeutic genetic engineering of autologous canine olfactory mucosal cells","volume":"9","author":"Delaney","year":"2017","journal-title":"Nanoscale"},{"key":"ref_105","doi-asserted-by":"crossref","first-page":"308","DOI":"10.1016\/j.nano.2018.12.018","article-title":"Non-viral vectors based on cationic niosomes and minicircle DNA technology enhance gene delivery efficiency for biomedical applications in retinal disorders","volume":"17","author":"Gallego","year":"2019","journal-title":"Nanomed. Nanotechnol. Biol. Med."},{"key":"ref_106","doi-asserted-by":"crossref","first-page":"7241","DOI":"10.1021\/nn402657d","article-title":"Development of poly(\u03b2-amino ester)-based biodegradable nanoparticles for nonviral delivery of minicircle DNA","volume":"7","author":"Keeney","year":"2013","journal-title":"ACS Nano"},{"key":"ref_107","doi-asserted-by":"crossref","first-page":"488","DOI":"10.1016\/j.jconrel.2015.09.046","article-title":"Exploring the role of polymer structure on intracellular nucleic acid delivery via polymeric nanoparticles","volume":"219","author":"Bishop","year":"2015","journal-title":"J. Control. Release Off. J. Control. Release Soc."},{"key":"ref_108","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1186\/s12943-024-02211-8","article-title":"Lipid nanoparticles deliver DNA-encoded biologics and induce potent protective immunity","volume":"24","author":"Chai","year":"2025","journal-title":"Mol. Cancer"},{"key":"ref_109","doi-asserted-by":"crossref","first-page":"862","DOI":"10.1089\/hum.2017.123","article-title":"Minicircle Versus Plasmid DNA Delivery by Receptor-Targeted Polyplexes","volume":"28","author":"Levacic","year":"2017","journal-title":"Hum. Gene Ther."},{"key":"ref_110","doi-asserted-by":"crossref","first-page":"2575","DOI":"10.1016\/j.drudis.2021.06.008","article-title":"Methods to improve the immunogenicity of plasmid DNA vaccines","volume":"26","author":"Neves","year":"2021","journal-title":"Drug Discov. Today"},{"key":"ref_111","doi-asserted-by":"crossref","first-page":"9827","DOI":"10.1038\/s41467-025-65713-z","article-title":"The methyl-CpG-binding protein 2 inhibits cGAS-associated signaling","volume":"16","author":"Chamma","year":"2025","journal-title":"Nat. Commun."},{"key":"ref_112","doi-asserted-by":"crossref","first-page":"107131","DOI":"10.1016\/j.jddst.2025.107131","article-title":"Nanoengineered innovations on DNA delivery systems for targeted cancer therapy","volume":"111","author":"Nunes","year":"2025","journal-title":"J. Drug Deliv. Sci. Technol."},{"key":"ref_113","doi-asserted-by":"crossref","unstructured":"Shariati, A., Khezrpour, A., Shariati, F., Afkhami, H., Yarahmadi, A., Alavimanesh, S., Kamrani, S., Modarressi, M.H., and Khani, P. (2025). DNA vaccines as promising immuno-therapeutics against cancer: A new insight. Front. Immunol., 15.","DOI":"10.3389\/fimmu.2024.1498431"},{"key":"ref_114","doi-asserted-by":"crossref","first-page":"15235","DOI":"10.2147\/IJN.S557690","article-title":"Nanomaterial-Enhanced Immunotherapy: Advancing T-Cell-Based Treatments for Bladder Cancer","volume":"20","author":"Chen","year":"2025","journal-title":"Int. J. Nanomed."},{"key":"ref_115","doi-asserted-by":"crossref","first-page":"106960","DOI":"10.1016\/j.jddst.2025.106960","article-title":"Exploring natural components in vaccine delivery systems: Types, routes of administration, in-vitro and in-vivo quantification techniques","volume":"108","author":"Sugandhi","year":"2025","journal-title":"J. Drug Deliv. Sci. Technol."},{"key":"ref_116","doi-asserted-by":"crossref","first-page":"100342","DOI":"10.1016\/j.crbiot.2025.100342","article-title":"Advancing recombinant protein production by bacteria: Strategies and challenges in heterologous systems","volume":"10","author":"Chander","year":"2025","journal-title":"Curr. Res. Biotechnol."},{"key":"ref_117","doi-asserted-by":"crossref","unstructured":"Liu, L., Morrow, M.P., and Bagarazzi, M. (2017). Clinical use of DNA vaccines. Handbook of Electroporation, Springer.","DOI":"10.1007\/978-3-319-32886-7_106"},{"key":"ref_118","doi-asserted-by":"crossref","first-page":"100063","DOI":"10.1016\/j.preme.2026.100063","article-title":"Advanced Therapy Medicinal Products: Emerging Therapeutic Frontiers and Evolving Regulatory Landscapes","volume":"3","author":"Bucciarelli","year":"2026","journal-title":"Precis. Med. Eng."},{"key":"ref_119","doi-asserted-by":"crossref","unstructured":"Yang, S., Hu, X., Zhu, J., Zheng, B., Bi, W., Wang, X., Wu, J., Mi, Z., and Wu, Y. (2025). Aspects and Implementation of Pharmaceutical Quality by Design from Conceptual Frameworks to Industrial Applications. Pharmaceutics, 17.","DOI":"10.3390\/pharmaceutics17050623"},{"key":"ref_120","doi-asserted-by":"crossref","first-page":"1047","DOI":"10.1016\/j.tibtech.2020.04.008","article-title":"Minicircle DNA: The future for DNA-based vectors?","volume":"38","author":"Almeida","year":"2020","journal-title":"Trends Biotechnol."},{"key":"ref_121","doi-asserted-by":"crossref","first-page":"2942","DOI":"10.1038\/s41596-024-01138-0","article-title":"Circular vectors as an efficient, fully synthetic, cell-free approach for preparing small circular DNA as a plasmid substitute for guide RNA expression in CRISPR\u2013Cas9 genome editing","volume":"20","author":"Oliynyk","year":"2025","journal-title":"Nat. Protoc."},{"key":"ref_122","doi-asserted-by":"crossref","first-page":"115340","DOI":"10.1016\/j.addr.2024.115340","article-title":"A comprehensive comparison of DNA and RNA vaccines","volume":"210","author":"Wang","year":"2024","journal-title":"Adv. Drug Deliv. Rev."},{"key":"ref_123","doi-asserted-by":"crossref","first-page":"1078","DOI":"10.1038\/s41578-021-00358-0","article-title":"Lipid nanoparticles for mRNA delivery","volume":"6","author":"Hou","year":"2021","journal-title":"Nat. Rev. Mater."},{"key":"ref_124","doi-asserted-by":"crossref","first-page":"2464","DOI":"10.1038\/s41467-026-68818-1","article-title":"Lipid Nanoparticle Database towards structure-function modeling and data-driven design for nucleic acid delivery","volume":"17","author":"Collins","year":"2026","journal-title":"Nat. Commun."},{"key":"ref_125","doi-asserted-by":"crossref","first-page":"222","DOI":"10.1038\/nbt.3802","article-title":"Overcoming cellular barriers for RNA therapeutics","volume":"35","author":"Dowdy","year":"2017","journal-title":"Nat. Biotechnol."},{"key":"ref_126","doi-asserted-by":"crossref","first-page":"114416","DOI":"10.1016\/j.addr.2022.114416","article-title":"The role of lipid components in lipid nanoparticles for vaccines and gene therapy","volume":"188","author":"Albertsen","year":"2022","journal-title":"Adv. Drug Deliv. Rev."},{"key":"ref_127","doi-asserted-by":"crossref","first-page":"e10213","DOI":"10.1002\/btm2.10213","article-title":"Cytosolic delivery of nucleic acids: The case of ionizable lipid nanoparticles","volume":"6","author":"Schlich","year":"2021","journal-title":"Bioeng. Transl. Med."},{"key":"ref_128","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1186\/s12967-022-03325-7","article-title":"Exosomes as bio-inspired nanocarriers for RNA delivery: Preparation and applications","volume":"20","author":"Amiri","year":"2022","journal-title":"J. Transl. Med."},{"key":"ref_129","doi-asserted-by":"crossref","unstructured":"Wallen, M., Aqil, F., Spencer, W., and Gupta, R.C. (2023). Exosomes as an emerging plasmid delivery vehicle for gene therapy. Pharmaceutics, 15.","DOI":"10.3390\/pharmaceutics15071832"},{"key":"ref_130","doi-asserted-by":"crossref","first-page":"7137","DOI":"10.2147\/IJN.S464249","article-title":"Engineering exosomes for therapeutic applications: Decoding biogenesis, content modification, and cargo loading strategies","volume":"19","author":"Bahadorani","year":"2024","journal-title":"Int. J. Nanomed."},{"key":"ref_131","doi-asserted-by":"crossref","first-page":"102","DOI":"10.1080\/14760584.2023.2292772","article-title":"The use of electroporation to deliver DNA-based vaccines","volume":"23","author":"Kisakov","year":"2024","journal-title":"Expert Rev. Vaccines"},{"key":"ref_132","doi-asserted-by":"crossref","unstructured":"Ledesma-Feliciano, C., Chapman, R., Hooper, J.W., Elma, K., Zehrung, D., Brennan, M.B., and Spiegel, E.K. (2023). Improved DNA vaccine delivery with needle-free injection systems. Vaccines, 11.","DOI":"10.3390\/vaccines11020280"},{"key":"ref_133","doi-asserted-by":"crossref","unstructured":"Mayrhofer, P., Schleef, M., and Jechlinger, W. (2009). Use of minicircle plasmids for gene therapy. Gene Therapy of Cancer: Methods and Protocols, Humana.","DOI":"10.1007\/978-1-59745-561-9_4"},{"key":"ref_134","doi-asserted-by":"crossref","first-page":"560","DOI":"10.1038\/s41434-021-00254-w","article-title":"CARAMBA: A first-in-human clinical trial with SLAMF7 CAR-T cells prepared by virus-free Sleeping Beauty gene transfer to treat multiple myeloma","volume":"28","author":"Prommersberger","year":"2021","journal-title":"Gene Ther."},{"key":"ref_135","doi-asserted-by":"crossref","unstructured":"Gote, V., Bolla, P.K., Kommineni, N., Butreddy, A., Nukala, P.K., Palakurthi, S.S., and Khan, W. (2023). A Comprehensive Review of mRNA Vaccines. Int. J. Mol. Sci., 24.","DOI":"10.3390\/ijms24032700"},{"key":"ref_136","doi-asserted-by":"crossref","unstructured":"Hajiaghapour Asr, M., Dayani, F., Saedi Segherloo, F., Kamedi, A., Neill, A.O., MacLoughlin, R., and Doroudian, M. (2023). Lipid Nanoparticles as Promising Carriers for mRNA Vaccines for Viral Lung Infections. Pharmaceutics, 15.","DOI":"10.3390\/pharmaceutics15041127"},{"key":"ref_137","doi-asserted-by":"crossref","first-page":"276","DOI":"10.1186\/s12951-022-01478-7","article-title":"Recent advances in mRNA-LNP therapeutics: Immunological and pharmacological aspects","volume":"20","author":"Kiaie","year":"2022","journal-title":"J. Nanobiotechnol."},{"key":"ref_138","doi-asserted-by":"crossref","first-page":"1467","DOI":"10.2174\/0115680266325847241121034100","article-title":"A Comprehensive Review of mRNA-based Vaccines for COVID-19, A New Era in Pharmaceuticals: Unspecified and Unknown Aspects, Effects and Challenges","volume":"25","author":"Vosoughi","year":"2025","journal-title":"Curr. Top. Med. Chem."},{"key":"ref_139","doi-asserted-by":"crossref","first-page":"403","DOI":"10.1056\/NEJMoa2035389","article-title":"Efficacy and Safety of the mRNA-1273 SARS-CoV-2 Vaccine","volume":"384","author":"Baden","year":"2021","journal-title":"N. Engl. J. Med."},{"key":"ref_140","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1038\/s41541-026-01382-3","article-title":"Durability of DNA-LNP and mRNA-LNP vaccine-induced immunity against SARS-CoV-2 xbb.1.5","volume":"11","author":"Tamming","year":"2026","journal-title":"npj Vaccines"},{"key":"ref_141","doi-asserted-by":"crossref","first-page":"2939","DOI":"10.1002\/jmv.27688","article-title":"Characterization of the significant decline in humoral immune response six months post-SARS-CoV-2 mRNA vaccination: A systematic review","volume":"94","author":"Notarte","year":"2022","journal-title":"J. Med. Virol."},{"key":"ref_142","doi-asserted-by":"crossref","first-page":"6984","DOI":"10.1016\/j.vaccine.2021.10.038","article-title":"COVID-19 vaccine\u2014Long term immune decline and breakthrough infections","volume":"39","author":"Khoury","year":"2021","journal-title":"Vaccine"},{"key":"ref_143","doi-asserted-by":"crossref","first-page":"156356","DOI":"10.1155\/2014\/156356","article-title":"Durable expression of minicircle DNA-liposome-delivered androgen receptor cDNA in mice with hepatocellular carcinoma","volume":"2014","author":"Chang","year":"2014","journal-title":"Biomed. Res. Int."},{"key":"ref_144","doi-asserted-by":"crossref","first-page":"2281733","DOI":"10.1080\/21645515.2023.2281733","article-title":"Delineation of DNA and mRNA COVID-19 vaccine-induced immune responses in preclinical animal models","volume":"19","author":"Andrade","year":"2023","journal-title":"Hum. Vaccines Immunother."},{"key":"ref_145","doi-asserted-by":"crossref","unstructured":"Valentin, A., Bergamaschi, C., Rosati, M., Angel, M., Burns, R., Agarwal, M., Gergen, J., Petsch, B., Oostvogels, L., and Loeliger, E. (2022). Comparative immunogenicity of an mRNA\/LNP and a DNA vaccine targeting HIV gag conserved elements in macaques. Front. Immunol., 13.","DOI":"10.3389\/fimmu.2022.945706"},{"key":"ref_146","doi-asserted-by":"crossref","first-page":"4206","DOI":"10.1016\/j.vaccine.2023.06.013","article-title":"Immune response enhancement with GLS-5310 DNA primary vaccine against SARS-CoV-2 followed by administration of an mRNA vaccine heterologous boost","volume":"41","author":"Kim","year":"2023","journal-title":"Vaccine"},{"key":"ref_147","first-page":"A1686","article-title":"1141 Immunization with plasmid DNA versus messenger RNA encapsulated in lipid nanoparticles leads to differences in immunological outcomes","volume":"11","author":"Moseman","year":"2023","journal-title":"J. Immunother. Cancer"},{"key":"ref_148","doi-asserted-by":"crossref","unstructured":"Liu, J., Hinson, D.T., Hansen, M.J., Van Keulen, V.P., Parrett, B.J., Pease, L.R., and Barry, M.A. (2026). Comparison of Immune Cell Transfection by Different Vaccine Vectors After Intradermal Injection. Vaccines, 14.","DOI":"10.20944\/preprints202601.0018.v1"},{"key":"ref_149","first-page":"1253","article-title":"Minicircle-DNA production by site specific recombination and protein\u2013DNA interaction chromatography","volume":"10","author":"Mayrhofer","year":"2008","journal-title":"J. Gene Med. A Cross-Discip. J. Res. Sci. Gene Transf. Its Clin. Appl."}],"container-title":["Vaccines"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/2076-393X\/14\/7\/563\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,6,26]],"date-time":"2026-06-26T09:52:15Z","timestamp":1782467535000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/2076-393X\/14\/7\/563"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,6,26]]},"references-count":149,"journal-issue":{"issue":"7","published-online":{"date-parts":[[2026,7]]}},"alternative-id":["vaccines14070563"],"URL":"https:\/\/doi.org\/10.3390\/vaccines14070563","relation":{},"ISSN":["2076-393X"],"issn-type":[{"value":"2076-393X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,6,26]]}}}